...
首页> 外文期刊>Journal of neuroinflammation >Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α
【24h】

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α

机译:棕榈酰乙醇酰胺通过过氧化物酶体增殖物激活受体-α在混合的神经胶质细胞培养物和器官型海马切片中发挥神经保护作用

获取原文

摘要

Background In addition to cytotoxic mechanisms directly impacting neurons, β-amyloid (Aβ)-induced glial activation also promotes release of proinflammatory molecules that may self-perpetuate reactive gliosis and damage neighbouring neurons, thus amplifying neuropathological lesions occurring in Alzheimer's disease (AD). Palmitoylethanolamide (PEA) has been studied extensively for its anti-inflammatory, analgesic, antiepileptic and neuroprotective effects. PEA is a lipid messenger isolated from mammalian and vegetable tissues that mimics several endocannabinoid-driven actions, even though it does not bind to cannabinoid receptors. Some of its pharmacological properties are considered to be dependent on the expression of peroxisome proliferator-activated receptors-α (PPARα). Findings In the present study, we evaluated the effect of PEA on astrocyte activation and neuronal loss in models of Aβ neurotoxicity. To this purpose, primary rat mixed neuroglial co-cultures and organotypic hippocampal slices were challenged with Aβ1-42 and treated with PEA in the presence or absence of MK886 or GW9662, which are selective PPARα and PPARγ antagonists, respectively. The results indicate that PEA is able to blunt Aβ-induced astrocyte activation and, subsequently, to improve neuronal survival through selective PPARα activation. The data from organotypic cultures confirm that PEA anti-inflammatory properties implicate PPARα mediation and reveal that the reduction of reactive gliosis subsequently induces a marked rebound neuroprotective effect on neurons. Conclusions In line with our previous observations, the results of this study show that PEA treatment results in decreased numbers of infiltrating astrocytes during Aβ challenge, resulting in significant neuroprotection. PEA could thus represent a promising pharmacological tool because it is able to reduce Aβ-evoked neuroinflammation and attenuate its neurodegenerative consequences.
机译:背景技术除了直接影响神经元的细胞毒性机制外,β-淀粉样蛋白(Aβ)诱导的神经胶质活化还促进促炎分子的释放,这些分子可能会自我维持反应性神经胶质增生并损害周围神经元,从而放大阿尔茨海默病(AD)中发生的神经病理学损害。棕榈酰乙醇酰胺(PEA)因其抗炎,止痛,抗癫痫和神经保护作用而被广泛研究。 PEA是一种从哺乳动物和植物组织中分离出来的脂质信使,尽管它不与大麻素受体结合,但它模仿了几种由内源性大麻素驱动的作用。它的某些药理特性被认为取决于过氧化物酶体增殖物激活受体-α(PPARα)的表达。研究结果在本研究中,我们评估了PEA对Aβ神经毒性模型中星形胶质细胞激活和神经元丢失的影响。为此,在有或没有分别为选择性PPARα和PPARγ拮抗剂的MK886或GW9662的存在下,用Aβ1-42攻击原代大鼠混合神经胶质共培养物和器官型海马切片,并用PEA处理。结果表明,PEA能够钝化Aβ诱导的星形胶质细胞活化,随后通过选择性PPARα活化改善神经元存活。来自器官型培养物的数据证实,PEA的抗炎特性暗示了PPARα的介导作用,并揭示出反应性神经胶质细胞减少的减少随后对神经元产生了明显的反弹神经保护作用。结论与我们之前的观察结果一致,本研究结果表明PEA治疗可导致Aβ攻击期间浸润性星形胶质细胞数量减少,从而显着保护神经。因此,PEA可以代表一种有前途的药理学工具,因为它能够减少Aβ引起的神经炎症并减轻其神经退行性后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号